Position
Chief Business Officer
Company
Climb Bio, Inc.
Wellesley HillsBiotechnologyHealthcareHealth CareresearchDescription
Climb Bio, Inc. has appointed Perrin Wilson, Ph.D., as its new Chief Business Officer. Dr Wilson, with over 17 years of experience in the pharmaceutical and biotech industries, will spearhead pre-commercial planning, communications, and business development.
Quick answer
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer (February 25, 2025). Climb Bio, Inc. is based in Wellesley Hills, Massachusetts, United States.
- Who is the new Chief Business Officer at Climb Bio, Inc?
- Climb Bio, Inc. named Perrin Wilson Chief Business Officer, announced February 25, 2025.
- What did Climb Bio, Inc. announce on February 25, 2025?
- Climb Bio, Inc. has appointed Perrin Wilson, Ph.D., as its new Chief Business Officer. Dr Wilson, with over 17 years of experience in the pharmaceutical and biotech industries, will spearhead pre-commercial planning, communications, and business development.
- What does Climb Bio, Inc. do?
- Eliem Therapeutics is developing life-changing therapies for nervous system disorders.
- Where is Climb Bio, Inc. based?
- Climb Bio, Inc. is based in Wellesley Hills, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Xeris Biopharma Holdings (February 25, 2025), Crinetics Pharmaceuticals (February 26, 2025), Microbot Medical (March 4, 2025) and SAGE Therapeutics (March 7, 2025) also announced leadership changes within 45 days of Climb Bio, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and research
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Dr. Anh Nguyen Appointed as Xeris' Chief Medical Officer succeeding Ken Johnson PharmD, SVP, Global Development and Medical Affairs (February 25, 2025)
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Microbot Medical Appoints Paul Mullen as Vice President of Sales for LIBERTY® Endovascular Robotic System (March 4, 2025)
- Sage Therapeutics appoints Michael Quirk, Ph.D. as Chief Medical Officer after Laura Gault steps down (March 7, 2025)
- Affinia Therapeutics Appoints Hideo Makimura, M.D., Ph.D. as Chief Medical Officer (February 5, 2025)
- Igor Matushansky, MD, PhD, Joins Immuneering as Chief Medical Officer (March 20, 2025)
Who to call at Climb Bio, Inc., and when
A new leader at Climb Bio, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Climb Bio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Climb Bio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Climb Bio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Climb Bio, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Climb Bio, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.